Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Willers

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinityAlberta Lucchese, Jörg Willers, Abraham Mittelman, et al.
Experimental Dermatology|June 11, 2005
Expression of melanoma-associated antigens in melanoma cell culturesMirjana Urosevic, Bettina Braun, Jörg Willers, et al.
Experimental Dermatology|June 11, 2005
Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysisJörg Willers, Alberta Lucchese, Abraham Mittelman, et al.
The Journal of Investigative Dermatology|September 18, 2004
Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database miningAbraham Mittelman, Raj Tiwari, Guglielmo Lucchese, et al.
Studies in Health Technology and Informatics|June 24, 2020
SPHN - Development and Usability Testing of an Electronic General Consent PrototypeJulia Maurer, Ramon Saccilotto, Jörg Willers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligandJörg Willers, Reinhard Dummer, Werner Kempf, et al.
International Journal of Cancer|July 15, 2004
Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patientsReinhard Dummer, Abraham Mittelman, Francesco P Fanizzi, et al.
Melanoma Research|August 12, 2004
Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patientsKarin Murer, Mirjana Urosevic, Jörg Willers, et al.
British Journal of Haematology|August 30, 2002
The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomasCornelia Schwab, Jörg Willers, Eva Niederer, et al.
International Journal of Cancer|April 12, 2002
Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviationsRalf Geertsen, Roland Böni, Rainer Blasczyk, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinityAlberta Lucchese, Jörg Willers, Abraham Mittelman, et al.
Experimental Dermatology|June 11, 2005
Expression of melanoma-associated antigens in melanoma cell culturesMirjana Urosevic, Bettina Braun, Jörg Willers, et al.
Experimental Dermatology|June 11, 2005
Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysisJörg Willers, Alberta Lucchese, Abraham Mittelman, et al.
The Journal of Investigative Dermatology|September 18, 2004
Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database miningAbraham Mittelman, Raj Tiwari, Guglielmo Lucchese, et al.
Studies in Health Technology and Informatics|June 24, 2020
SPHN - Development and Usability Testing of an Electronic General Consent PrototypeJulia Maurer, Ramon Saccilotto, Jörg Willers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligandJörg Willers, Reinhard Dummer, Werner Kempf, et al.
International Journal of Cancer|July 15, 2004
Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patientsReinhard Dummer, Abraham Mittelman, Francesco P Fanizzi, et al.
Melanoma Research|August 12, 2004
Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patientsKarin Murer, Mirjana Urosevic, Jörg Willers, et al.
British Journal of Haematology|August 30, 2002
The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomasCornelia Schwab, Jörg Willers, Eva Niederer, et al.
International Journal of Cancer|April 12, 2002
Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviationsRalf Geertsen, Roland Böni, Rainer Blasczyk, et al.
Pageof 2